Invenomic Capital Management’s FIVE9 FIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19M Sell
892,658
-44,130
-5% -$871K 1.14% 32
2026
Q1
$14.2M Buy
936,788
+670,536
+252% +$11.7M 0.65% 56
2025
Q4
$5.34M Buy
+266,252
New +$5.65M 0.25% 108

Other funds holding FIVN

Invenomic Capital Management's FIVN Position: Q2 2026 in Review

Invenomic Capital Management reduced its FIVE9 (FIVN) stake by 4.7% in Q2 2026, selling an estimated $871K and leaving 892,658 shares worth $19M. The position accounts for 1.14% of the portfolio, ranked #32.

Invenomic Capital Management first reported a position in FIVN in Q4 2025 and has held it in 3 quarters since. 290 funds tracked by Wall St. Rank hold FIVN as of Q2 2026.

  • Invenomic Capital Management held 892,658 shares of FIVE9 worth $19M as of Q2 2026.
  • Invenomic Capital Management sold 44,130 FIVE9 shares in Q2 2026, an estimated $871K.
  • FIVE9 made up 1.14% of Invenomic Capital Management's portfolio in Q2 2026, its #32 holding.
  • Invenomic Capital Management first reported a position in FIVE9 in Q4 2025 and has held it in 3 quarters since.
  • 290 funds tracked by Wall St. Rank held FIVE9 as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.